vimarsana.com

Latest Breaking News On - Pharma stock recommendations - Page 1 : vimarsana.com

Goldman picks 2 pharma stocks, screams sells on Laurus Labs

Goldman Sachs ratings triggered price movements, with Syngene and Neuland rising but Laurus falling. Syngene is set to benefit from China+1, while Neuland sees growth opportunities in APIs and chemistry solutions. In contrast, Laurus faces challenges in its business transition and growth prospects.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.